Other studies have identified a claudin-low (CL) subtype of TNBC, characterized by low expression of genes involved in tight junctions and epithelial cell-cell adhesion, including claudin 3, 4 and 7, E-cadherin and occludin, and exhibiting chemotherapy-resistant properties [5, 6]
Insulin-based glycaemic control is the pharmacological cornerstone in type 1 diabetes and delays the onset and progression of kidney disease
They concluded that NACA may be a novel treatment in rescuing retinal function and preventing vision loss secondary to retinal degenerative diseases including AMD
Our GLP-1 meal plan guide covers this in detail
I will take in a list to show roughly dates of when I had symptoms and when I had B12 etc, so that they have an idea on the progression of all of this, so I don't just go in and reel off a list of symptoms and the poor GP is just sat there baffled thinking